Proposed Data Collection Submitted for Public Comment and Recommendations, 53308-53309 [2021-20844]
Download as PDF
<![CDATA[
53308
Federal Register / Vol. 86, No. 184 / Monday, September 27, 2021 / Notices
3. For both preventive interventions
and diagnostic/treatment services in
your workplace, please describe how
widely the services are used, how
stigma associated with seeking mental
health care is addressed, and how
health workers are encouraged to
participate. In your experience, how
does the workplace benefit from
implementing interventions or offering
services to health workers to prevent/
reduce work-related stress, to decrease
stigma related to seeking and receiving
care, and to improve the mental health
and well-being of health workers?
4. Please describe any programs you
are aware of that help employers to fund
or otherwise develop interventions or
services to support health worker
mental health and well-being.
Questions About Workplaces
5. Please tell us about your experience
with any workplace policies designed to
protect workers from stress and adverse
mental health outcomes and to address
these issues. Describe the part(s) of your
organization involved in workassociated stress prevention efforts.
lotter on DSK11XQN23PROD with NOTICES1
Questions About Health Workers’
Communication Preferences
6. Please tell us about your
workplace’s most effective methods of
informing health workers about
available interventions, services, and
workplace practices and policies,
including but not limited to:
Notification channels, trusted
messengers (e.g., upper management,
front line supervisor, union
representatives), and efforts to reach
workers who are underserved by mental
health/behavioral health resources.
7. In your experience, do workers seek
mental health and well-being
information outside the workplace and,
if so, where (e.g., community-based,
faith-based)? Do health workers
generally find sources of information
outside the workplace more trustworthy
and credible than employer-based
programs? If so, what is the basis for this
understanding and what efforts have
you undertaken to address such
concerns?
In addition to the specific questions
above, NIOSH would also like to hear
from researchers currently conducting
research on stress, burnout, and other
VerDate Sep<11>2014
18:08 Sep 24, 2021
Jkt 253001
mental health and well-being concerns
among a broad range of health workers.
John J. Howard,
Administrator, World Trade Center Health
Program and Director, National Institute for
Occupational Safety and Health, Centers for
Disease Control and Prevention, Department
of Health and Human Services.
[FR Doc. 2021–20931 Filed 9–24–21; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–21–0210; Docket No. CDC–2021–
0102]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
continuing information collection
project titled List of Ingredients Added
to Tobacco in the Manufacture of
Cigarette Products. The proposed
collection allows CDC’s Office of
Smoking and Health (OSH) to collect
information about the ingredients used
in cigarette products, a responsibility
that has been delegated to CDC by HHS.
DATES: CDC must receive written
comments on or before November 26,
2021.
SUMMARY:
You may submit comments,
identified by Docket No. CDC–2021–
0102 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS–H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
ADDRESSES:
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
Please note: Submit all comments through
the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
H21–8, Atlanta, Georgia 30329; phone:
404–639–7570; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
FOR FURTHER INFORMATION CONTACT:
Proposed Project
List of Ingredients Added to Tobacco
in the Manufacture of Cigarette Products
(OMB Control No. 0920–0210, Exp.
4/30/2022)—Extension—National
Center for Chronic Disease Prevention
and Health Promotion (NCCDPHP),
E:\FR\FM\27SEN1.SGM
27SEN1
53309
Federal Register / Vol. 86, No. 184 / Monday, September 27, 2021 / Notices
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
Cigarette smoking is the leading
preventable cause of premature death
and disability in our nation. Each year
more than 480,000 deaths occur as the
result of cigarette smoking-related
diseases. The CDC’s Office on Smoking
and Health (OSH) is the lead federal
agency for comprehensive tobacco
prevention and control. Since 1986, as
required by the Comprehensive
Smoking Education Act (CSEA) of 1984,
which amended the Federal Cigarette
Labeling and Advertising Act (FCLAA),
15 U.S.C. 1335a, CDC has collected
information about the ingredients used
in cigarette products. HHS has delegated
responsibility for implementing the
required information collection to CDC’s
OSH. Respondents are commercial
cigarette manufacturers, packagers, or
importers (or their representatives), who
Attention: FCLAA Program Manager,
Office on Smoking and Health, National
Center for Chronic Disease Prevention
and Health Promotion, Centers for
Disease Control and Prevention, 4770
Buford Highway NE, MS S107–7,
Atlanta, GA 30341–3717.
Upon receipt and verification of the
annual ingredient report, CDC issues a
Certificate of Compliance to the
respondent. As deemed appropriate by
the Secretary of HHS, HHS is authorized
to use the information to report to
Congress the health effects of
ingredients, research activities related to
the health effects of ingredients, and
other information that the Secretary
determines to be of public interest.
There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
358. OMB approval is requested for
three years.
are required by FCLAA to submit
ingredient reports to HHS on an annual
basis.
Respondents are not required to
submit specific forms; however, they are
required to submit a list of all
ingredients used in their products. CDC
requires the ingredient report to be
submitted by chemical name and
Chemical Abstract Service (CAS)
Registration Number, consistent with
accepted reporting practices for other
companies currently required to report
ingredients added to other consumer
products. The information collected is
subject to strict confidentiality
provisions.
Ingredient reports are due annually on
March 31. Information is submitted to
CDC by mailing or faxing a written
report on the respondent’s letterhead.
All faxed lists should be followed up
with a mailed original. Electronic mail
submissions are not accepted. Mail
Annual Ingredient Submissions to
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total burden
(in hours)
Form name
Business Entities ...............................
N/A ...................................................
55
1
6.5
358
Total ...........................................
...........................................................
........................
........................
........................
358
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2021–20844 Filed 9–24–21; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–21–0666; Docket No. CDC–2021–
0100]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
SUMMARY:
VerDate Sep<11>2014
18:08 Sep 24, 2021
Jkt 253001
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled National Healthcare Safety
Network (NHSN). NHSN is the nation’s
most widely used healthcare-associated
infection tracking system, providing
facilities, states, regions, and the nation
with data needed to identify problem
areas, measure progress of prevention
efforts, and ultimately eliminate
healthcare-associated infections.
DATES: CDC must receive written
comments on or before November 26,
2021.
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE,
Mailstop H21–8, Atlanta, Georgia 30329;
phone: 404–639–7570; Email: omb@
cdc.gov.
You may submit comments,
identified by Docket No. CDC–2020–
0100 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, Mailstop H21–8,
Atlanta, Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
SUPPLEMENTARY INFORMATION:
ADDRESSES:
AGENCY:
lotter on DSK11XQN23PROD with NOTICES1
Number of
respondents
Type of respondents
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
E:\FR\FM\27SEN1.SGM
27SEN1
]]>Agencies
[Federal Register Volume 86, Number 184 (Monday, September 27, 2021)]
[Notices]
[Pages 53308-53309]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-20844]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-21-0210; Docket No. CDC-2021-0102]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal agencies the opportunity to comment on a proposed and/or
continuing information collection, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a continuing
information collection project titled List of Ingredients Added to
Tobacco in the Manufacture of Cigarette Products. The proposed
collection allows CDC's Office of Smoking and Health (OSH) to collect
information about the ingredients used in cigarette products, a
responsibility that has been delegated to CDC by HHS.
DATES: CDC must receive written comments on or before November 26,
2021.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2021-
0102 by any of the following methods:
Federal eRulemaking Portal: Regulations.gov. Follow the
instructions for submitting comments.
Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS-H21-8, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to Regulations.gov.
Please note: Submit all comments through the Federal eRulemaking
portal (regulations.gov) or by U.S. mail to the address listed
above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS H21-8, Atlanta, Georgia 30329; phone: 404-639-7570; Email:
[email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
Federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected;
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses; and
5. Assess information collection costs.
Proposed Project
List of Ingredients Added to Tobacco in the Manufacture of
Cigarette Products (OMB Control No. 0920-0210, Exp. 4/30/2022)--
Extension--National Center for Chronic Disease Prevention and Health
Promotion (NCCDPHP),
[[Page 53309]]
Centers for Disease Control and Prevention (CDC).
Background and Brief Description
Cigarette smoking is the leading preventable cause of premature
death and disability in our nation. Each year more than 480,000 deaths
occur as the result of cigarette smoking-related diseases. The CDC's
Office on Smoking and Health (OSH) is the lead federal agency for
comprehensive tobacco prevention and control. Since 1986, as required
by the Comprehensive Smoking Education Act (CSEA) of 1984, which
amended the Federal Cigarette Labeling and Advertising Act (FCLAA), 15
U.S.C. 1335a, CDC has collected information about the ingredients used
in cigarette products. HHS has delegated responsibility for
implementing the required information collection to CDC's OSH.
Respondents are commercial cigarette manufacturers, packagers, or
importers (or their representatives), who are required by FCLAA to
submit ingredient reports to HHS on an annual basis.
Respondents are not required to submit specific forms; however,
they are required to submit a list of all ingredients used in their
products. CDC requires the ingredient report to be submitted by
chemical name and Chemical Abstract Service (CAS) Registration Number,
consistent with accepted reporting practices for other companies
currently required to report ingredients added to other consumer
products. The information collected is subject to strict
confidentiality provisions.
Ingredient reports are due annually on March 31. Information is
submitted to CDC by mailing or faxing a written report on the
respondent's letterhead. All faxed lists should be followed up with a
mailed original. Electronic mail submissions are not accepted. Mail
Annual Ingredient Submissions to Attention: FCLAA Program Manager,
Office on Smoking and Health, National Center for Chronic Disease
Prevention and Health Promotion, Centers for Disease Control and
Prevention, 4770 Buford Highway NE, MS S107-7, Atlanta, GA 30341-3717.
Upon receipt and verification of the annual ingredient report, CDC
issues a Certificate of Compliance to the respondent. As deemed
appropriate by the Secretary of HHS, HHS is authorized to use the
information to report to Congress the health effects of ingredients,
research activities related to the health effects of ingredients, and
other information that the Secretary determines to be of public
interest.
There are no costs to respondents other than their time. The total
estimated annualized burden hours are 358. OMB approval is requested
for three years.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response Total burden
respondents respondent (in hours) (in hours)
----------------------------------------------------------------------------------------------------------------
Business Entities............. N/A............. 55 1 6.5 358
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 358
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2021-20844 Filed 9-24-21; 8:45 am]
BILLING CODE 4163-18-P
